A
Andrea Bezjak
Researcher at Princess Margaret Cancer Centre
Publications - 293
Citations - 20806
Andrea Bezjak is an academic researcher from Princess Margaret Cancer Centre. The author has contributed to research in topics: Lung cancer & Radiation therapy. The author has an hindex of 62, co-authored 277 publications receiving 19027 citations. Previous affiliations of Andrea Bezjak include Ontario Institute for Cancer Research & University Health Network.
Papers
More filters
Book ChapterDOI
Primary Gastric Lymphoma: Brief Overview of the Recent Princess Margaret Hospital Experience
Mary Gospodarowicz,Melania Pintilie,Richard W. Tsang,B. Patterson,Andrea Bezjak,Woodrow Wells +5 more
TL;DR: The view that primary gastric lymphoma is a highly curable disease is supported, with a review of the Princess Margaret Hospital experience, to illustrate the favorable prognosis and examine the long-term outcomes.
Journal ArticleDOI
The influence of sex on efficacy, adverse events, quality of life, and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group non-small cell lung cancer chemotherapy trials.
Paul Wheatley-Price,Aurélie Le Maître,Keyue Ding,Natasha B. Leighl,Vera Hirsh,Lesley Seymour,Andrea Bezjak,Frances A. Shepherd +7 more
TL;DR: Women demonstrate modestly longer progression-free survival than men in chemotherapy-treated NSCLC, with no differences observed in response rates, serious AEs, or QoL.
Journal ArticleDOI
A phase I study of concurrent pemetrexed (P)/cisplatin (C)/radiation (RT) for unresectable stage IIIA/B non-small cell lung cancer (NSCLC)
Anthony Brade,Andrea Bezjak,Robert MacRae,Scott A. Laurie,Greg Pond,Luhua Wang,C. Dick,A. Afinec,Neill Iscoe,Frances A. Shepherd +9 more
TL;DR: Patients with unresectable stage III A/B NSCLC treated with concurrent chemoRT or no standard chemotherapy regimen/schedule are at increased risk of adverse events and need to be monitored for recurrence.
Journal ArticleDOI
Palliative therapy for lung cancer
TL;DR: The evidence for the role of various therapeutic modalities in palliation of thoracic symptoms, including external beam radiotherapy, brachytherapy, chemotherapy, photodynamic therapy, and vascular stents, is presented.
Journal ArticleDOI
Understanding the needs of lung cancer patients during the pre-diagnosis phase
David Wiljer,David Wiljer,David Wiljer,Tara Walton,Julie Gilbert,Julie Gilbert,Amy Boucher,Peter M. Ellis,Susan Schiff,Scott M Sellick,Marko Simunovic,Andrea Bezjak,Sara Urowitz,Sara Urowitz +13 more
TL;DR: During pre-diagnosis, informational and emotional needs appear most important, and for the majority, these were reportedly met; although many experienced high levels of anxiety, few were directed to resources to address it.